Cargando…

Enhancement of a T(H)1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis

In an attempt to investigate the effects of treatment of human leishmaniasis, the cytokines produced by peripheral blood mononuclear cells (PBMCs) of patients with cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL) under treatment with amphotericin B were determined during the active...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuna, Washington R., Velasquez, Rianed, Riva, Janeth, Guachalla, Ingrid, Rodríguez, Celeste
Formato: Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906706/
https://www.ncbi.nlm.nih.gov/pubmed/17641726
http://dx.doi.org/10.1155/2007/96410
_version_ 1782134013710827520
author Cuna, Washington R.
Velasquez, Rianed
Riva, Janeth
Guachalla, Ingrid
Rodríguez, Celeste
author_facet Cuna, Washington R.
Velasquez, Rianed
Riva, Janeth
Guachalla, Ingrid
Rodríguez, Celeste
author_sort Cuna, Washington R.
collection PubMed
description In an attempt to investigate the effects of treatment of human leishmaniasis, the cytokines produced by peripheral blood mononuclear cells (PBMCs) of patients with cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL) under treatment with amphotericin B were determined during the active disease from cocultures of cells and Leishmania (Viannia) braziliensis antigens. PBMC of these patients exhibited a nonsignificant marginal increased production of TNF-α upon antigen stimulation. However, under the same antigenic stimulus, patients with active MCL presented higher IFN-γ production compared to patients with CL. This increased IFN-γ production was accompanied by a drastically augmented IL-12 synthesis from cells of MCL patients. The highlighted T cell responses could be relevant for sound control measures of protozoan infections with emphasis on the combined usage of immunoenhancing agents and antiprotozoal drugs.
format Text
id pubmed-1906706
institution National Center for Biotechnology Information
language English
publishDate 2007
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-19067062007-07-19 Enhancement of a T(H)1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis Cuna, Washington R. Velasquez, Rianed Riva, Janeth Guachalla, Ingrid Rodríguez, Celeste J Biomed Biotechnol Research Article In an attempt to investigate the effects of treatment of human leishmaniasis, the cytokines produced by peripheral blood mononuclear cells (PBMCs) of patients with cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL) under treatment with amphotericin B were determined during the active disease from cocultures of cells and Leishmania (Viannia) braziliensis antigens. PBMC of these patients exhibited a nonsignificant marginal increased production of TNF-α upon antigen stimulation. However, under the same antigenic stimulus, patients with active MCL presented higher IFN-γ production compared to patients with CL. This increased IFN-γ production was accompanied by a drastically augmented IL-12 synthesis from cells of MCL patients. The highlighted T cell responses could be relevant for sound control measures of protozoan infections with emphasis on the combined usage of immunoenhancing agents and antiprotozoal drugs. Hindawi Publishing Corporation 2007 2007-06-11 /pmc/articles/PMC1906706/ /pubmed/17641726 http://dx.doi.org/10.1155/2007/96410 Text en Copyright © 2007 Washington R. Cuna et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Cuna, Washington R.
Velasquez, Rianed
Riva, Janeth
Guachalla, Ingrid
Rodríguez, Celeste
Enhancement of a T(H)1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis
title Enhancement of a T(H)1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis
title_full Enhancement of a T(H)1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis
title_fullStr Enhancement of a T(H)1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis
title_full_unstemmed Enhancement of a T(H)1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis
title_short Enhancement of a T(H)1 Immune Response in Amphotericin B-Treated Mucocutaneous Leishmaniasis
title_sort enhancement of a t(h)1 immune response in amphotericin b-treated mucocutaneous leishmaniasis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1906706/
https://www.ncbi.nlm.nih.gov/pubmed/17641726
http://dx.doi.org/10.1155/2007/96410
work_keys_str_mv AT cunawashingtonr enhancementofath1immuneresponseinamphotericinbtreatedmucocutaneousleishmaniasis
AT velasquezrianed enhancementofath1immuneresponseinamphotericinbtreatedmucocutaneousleishmaniasis
AT rivajaneth enhancementofath1immuneresponseinamphotericinbtreatedmucocutaneousleishmaniasis
AT guachallaingrid enhancementofath1immuneresponseinamphotericinbtreatedmucocutaneousleishmaniasis
AT rodriguezceleste enhancementofath1immuneresponseinamphotericinbtreatedmucocutaneousleishmaniasis